Invesco S&P 500 Momentum ETF vs UnitedHealth Group Inc — how do they compare? Invesco S&P 500 Momentum ETF trades at $149.97, while UnitedHealth Group Inc trades at $435.93 (market cap $382.83B). The key difference: UnitedHealth Group Inc pays a 2.2% dividend while Invesco S&P 500 Momentum ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, Invesco S&P 500 Momentum ETF nearer its low. Which is the better fit depends on your goals.
| SPMO | UNH | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $161.66 | $431.68 |
52-Week Low | $107.84 | $237.77 |
Market Cap | — | $382.83B |
Enterprise Value | — | $429.52B |
Dividend Yield | — | 2.2% |
Signals from Pluang's Aura AI — not financial advice
SPMO trades at $144.50, up 0.42% on the day, with a technical outlook leaning bearish based on moving averages despite neutral oscillators. The ETF has demonstrated strong momentum performance in 2026, with a 26% year-to-date return as of July 20, 2026 (247 Wallst). It maintains a concentrated, tech-heavy portfolio, heavily weighted toward AI beneficiaries, driving its outperformance versus the S&P 500.
Outlook remains positive for momentum-driven gains, supported by AI-fueled growth, but risks include high volatility and sensitivity to sector rotations. The upcoming $0.25 dividend in June 2026 provides additional shareholder return. Analyst sentiment is generally constructive, though the concentrated portfolio demands caution during market downturns.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →